skip to Main Content

Cresco Labs’ Dispensary Launches Newly Enacted Illinois Opioid Alternative Pilot Program

PRESS RELEASE CHICAGO--(BUSINESS WIRE)--Cresco Labs (CSE: CL) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced that the Company’s FloraMedex dispensary launched Illinois’ Opioid Alternative Pilot Program (OAPP) today vastly expanding…

Read More
Back To Top
×Close search
Search